Skip to main content

Advertisement

SpringerLink
Log in

Effects of fluconazole on the sterol and carbohydrate composition of four species ofCandida

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The effects of fluconazole, a bis-triazole antifungal agent, on the sterol and carbohydrate composition ofCandida albicans, Candida tropicalis, Candida krusei andCandida parapsilosis were investigated. Exposure ofCandida species to fluconazole resulted in a profound depletion of ergosterol with a corresponding increase in lanosterol content versus control cells. Carbohydrate analysis revealed a significant increase in chitin and either a decrease(Candida albicans, Candida tropicalis andCandida parapsilosis) or an increase(Candida krusei) in glucan content in fluconazole-treated cells. The decreased ergosterol and increased lanosterol content is consistnet with 14-alpha-demethylase inhibition by fluconazole. The increase in cell wall chitin is most likely due to deregulation of chitin synthesis secondary to ergosterol depletion in the cell membrane. Because chitin, glucan and ergosterol are critical components of the fungal cell, perturbation of the production and localization of these components by fluconazole is likely to contribute to the selective toxicity of this compound toCandida species and other fungi.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. DeWit S, Weert D, Goossens H, Clumeck N: Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989, i: 746–748.

    Article  Google Scholar 

  2. Galgiani JN: Fluconazole, a new antifungal agent. Annals of Internal Medicine 1990, 113: 177–179.

    PubMed  Google Scholar 

  3. Saag MS, Dismukes WE: Azole antifungal agents: emphasis on new triazoles. Antimicrobial Agents and Chemotherapy 1988, 32: 1–8.

    PubMed  Google Scholar 

  4. Sugar AM, Saunders C: Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. American Journal of Medicine 1988, 85: 481–491.

    PubMed  Google Scholar 

  5. Marriott MS, Richardson K: The discovery and mode of action of fluconazole. In: Fromtling RA (ed): Recent trends in the discovery, development, and evaluation of antifungal agents. JR Prous Science Publishers, Barcelona, 1987, p. 81–82.

    Google Scholar 

  6. Van den Bossche H: Biochemical targets for azole antifungal derivatives: hypothesis on the mode of action. In: McGinnis MR (ed): Current topics in medical mycology, Volume 1. Srpinger Verlag, New York, 1985, p. 313–351.

    Google Scholar 

  7. Van den Bossche H, Willemsens G, Cools W, Marichal P, Lauwers W: Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles. Biochemical Society Transactions 1983, 11: 665–667.

    PubMed  Google Scholar 

  8. Marichal P, Gorrens J, Van den Bossche H: The action of itraconazole and ketoconazole on growth and sterol synthesis inAspergillus fumigatus andAspergillus niger. Sabouraudia: Journal of Medical and Veterinary Mycology 1984, 22: 13–21.

    Google Scholar 

  9. Borgers M: Ultrastructural correlates of antimycotic treatment. In: McGinnis MR (ed): Current topics in medical mycology, Volume 2. Springer Verlag, New York, 1988, p. 1–39.

    Google Scholar 

  10. Pfaller MA, Riley J, Koerner T: Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition ofCandida albicans. Diagnostic Microbiology and Infectious Diseases 1990, 13: 31–35.

    Article  Google Scholar 

  11. Pfaller MA, Gerarden T: Susceptibility of clinical isolates ofCandida spp. to terconazole and other azole antifungal agents. Diagnostic Microbiology and Infectious Diseases 1989, 12: 467–471.

    Google Scholar 

  12. Milewski S, Chmara H, Borowski E: Antibiotic tetaine-a selective inhibitor of chitin and mannoprotein biosynthesis. Archives of Microbiology 1986, 145: 234–240.

    Article  PubMed  Google Scholar 

  13. Trevelyan WE, Harrison JS: Studies on yeast metabolism. Biochemical Journal 1952, 50: 298–303.

    PubMed  Google Scholar 

  14. Dische Z: Color reactions of hexosamines. In: Whistler RL, Wolfrom MZ (ed): Methods in carbohydrate chemistry. Academic Press, New York, 1962, p. 507–512.

    Google Scholar 

  15. Roberts RL, Blowers B, Slater ML, Cabib E: Chitin synthesis and localization in cell division cycle mutants ofSaaccharomyces cerevisiae. Molecular and Cell Biology 1983, 3: 922–930.

    Google Scholar 

  16. Rogers HJ, Perkins HR, Ward JB: Biosynthesis of cell walls and membranes. Chapman and Hall, London, 1980, p. 478–507.

    Google Scholar 

  17. Gooday GW: The enzymology of hyphal growth. In: Smith JE, Berry DR (ed): The filamentous fungi: developmental biology, Volume 3. Edward Arnold, London, 1978, p. 51–77.

    Google Scholar 

  18. Chiew YY, Sullivan PA, Shepherd MG: The effects of ergosterol and alcohols on germ-tube formation and chitin synthase inCandida albicans. Canadian Journal of Biochemistry 1982, 60: 15–20.

    PubMed  Google Scholar 

  19. Surarit R, Shepherd MG: The effects of azole and polyene antifungals on the plasma membrane enzymes ofCandida albicans. Journal of Medical and Veterinary Mycology 1987, 25: 403–413.

    PubMed  Google Scholar 

  20. Pfaller M, Riley J, Koerner T: Effects of cilofungin (LY121019) on carbohydrate and sterol composition ofCandida albicans. European Journal of Clinical Microbiology and Infectious Diseases 1989, 8: 1067–1070.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Veterans Affairs Medical Center, University of Iowa College of Medicine, 52242, Iowa City, Iowa, USA

    M. Pfaller & J. Riley

  2. Department of Pathology, 273 MRC, University of Iowa College of Medicine, 52242, Iowa City, Iowa, USA

    M. Pfaller

  3. Department of Pathology, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, 97201-3098, Portland, Oregon, USA

    M. Pfaller

Authors
  1. M. Pfaller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Riley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfaller, M., Riley, J. Effects of fluconazole on the sterol and carbohydrate composition of four species ofCandida . Eur. J. Clin. Microbiol. Infect. Dis. 11, 152–156 (1992). https://doi.org/10.1007/BF01967067

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967067

Keywords

Search

Navigation